Title abbreviation: Swiss Med Wkly
1871-1919: Correspondenz-Blatt für Schweizer Aerzte, ISSN 0366-5461
1920-2000: Schweizerische Medizinische Wochenschrift / Journal Suisse de Médecine, ISSN 0036-7672
Founded in 1871 under the name "Correspondenz-Blatt für Schweizer Aerzte" and later known as "Schweizerische Medizinische Wochenschrift", the Swiss Medical Weekly is a scientific publication with a long tradition.
Today it is an online journal with continuous online publication, published by the SMW supporting association.
SMW has played a decisive role in Swiss clinical research. Examples are the fundoplication described by R. Nissen in 1956, the first drug treatments for depression reported in 1957 by R. Kuhn, the first description of a haemolytic-uraemic syndrome by C. Gasser in 1955 and, a few years later, the enzymatic method for measuring blood glucose levels in our patients by R. Richterich. These historical publications were followed by many other articles with significant international impact.
Diamond open access
The SMW is a pioneer of Diamond Open Access publishing, having introduced open access to all articles without requiring authors to pay APCs even before the publication of the Berlin Declaration on Open Access.
Editorial quality and publication ethics are values that are uncompromisingly upheld by the editorial board. The Swiss Medical Weekly accepts for consideration original and review articles from all fields of medicine. The quality of SMW publications is guaranteed by a consistent policy of rigorous single-blind peer review. All editorial decisions are made by research-active academics.
SMW adheres to the “Principles of Transparency and Best Practice in Scholarly Publishing”. The "SMW supporting association" guarantees the editorial independence of the journal. The editors have total responsibility, authority, and accountability for the scientific content of the Swiss Medical Weekly. In order to maintain editorial independence, the principles formulated by the World Association of Medical Editors (“The Relationship Between Journal Editors-in-Chief and Owners”) are observed.
SMW is a member of COPE (Committee on Publication Ethics) and and follows its recommendations.
Official scientific publication of medical societies
The Swiss Medical Weekly is the official scientific publication of the Swiss Society of General Internal Medicine, the Swiss Society of Infectiology, the Swiss Society of Rheumatology and the Swiss Society of Pulmonary Hypertension.
Number of submissions (2022): 538
Average number of reviews requested per manuscript sent to reviewing: 6
Average number of reviews received per manuscript: 3
Approval rate: 24%
Time to first editorial decision (desktop rejection or peer review): 2 days
Average time to first decision: 21 days
Average time between submission and final decision: 80 days
Average time between final decision and publication: 14 days
Articles published in the Swiss Medical Weekly are preserved in CLOCKSS, a secure dark archive.
Published by the SMW supporting association
After the change from Schweizerische Medizinische Wochenschrift to Swiss Medical Weekly in 2001, the journal has been published as a journal of EMH Swiss Medical Publishers Ltd. Having assumed responsibility for the content and finances of the journal, the SMW supporting association now also acts as the journal's publisher.
Our open access model
SMW was one of the first journals to adhere to the principles of Diamond Open Access (also known as Platinum Open Access or Public Service Open Access). It has followed the Open Access model since the first OA declarations and initiatives.
Open access license
For all articles published after 01.01.2023, the following license applies:
Creative Commons license Attribution 4.0 International (CC BY 4.0)
You are free to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose
under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
OA license for older articles
For articles published before 2023, the licensing policy was "Attribution-NonCommercial-ShareAlike 4.0 International" (CC BY-NC-SA 4.0) or "Attribution-NonCommercial-NoDerivatives 4.0 International" (CC BY-NC-ND 4.0). You will find the corresponding information in the side column of the respective article.
Copyright and publishing rights
Authors are requested to grant the SMW sponsoring association a non-exclusive licence to publish. We do not ask authors to transfer copyright to us.
Authors are permitted to deposit all versions of their paper in an institutional or subject repository (preprint, author's accepted manuscript and published article (version of record).
We encourage research librarians to list this journal among their library's electronic journal holdings. As well, it may be worth noting that this journal's open source publishing system is suitable for libraries to host for their faculty members to use with journals they are involved in editing (see Open Journal Systems).